PRJNA561073
Exome sequincing of a series of vagal paragangliomas
To create more specific treatment strategies, there is a growing need for the identification of new biomarkers that can distinguish between indolent and aggressive metastatic forms of vagal paragangliomas. We have conducted whole exome study for a series of vagal paragangliomas in a search of prognostic markers for aggressiveness and malignancy.